OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Optimal Sequential Strategies for Antibody-Drug Conjugate in Metastatic Breast Cancer: Evaluating Efficacy and Cross-Resistance
Meiting Chen, Riqing Huang, R.C. Chen, et al.
The Oncologist (2024) Vol. 29, Iss. 8, pp. e957-e966
Open Access | Times Cited: 10
Meiting Chen, Riqing Huang, R.C. Chen, et al.
The Oncologist (2024) Vol. 29, Iss. 8, pp. e957-e966
Open Access | Times Cited: 10
Showing 10 citing articles:
The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development
Raffaele Colombo, Paolo Tarantino, Jamie R. Rich, et al.
Cancer Discovery (2024) Vol. 14, Iss. 11, pp. 2089-2108
Closed Access | Times Cited: 6
Raffaele Colombo, Paolo Tarantino, Jamie R. Rich, et al.
Cancer Discovery (2024) Vol. 14, Iss. 11, pp. 2089-2108
Closed Access | Times Cited: 6
Real-world safety and effectiveness data of trastuzumab deruxtecan and sacituzumab govitecan in breast cancer: a Hellenic Cooperative Oncology Group study
Elena Fountzilas, Sofia Karageorgopoulou, Georgios Karakatsoulis, et al.
ESMO Real World Data and Digital Oncology (2025) Vol. 7, pp. 100095-100095
Closed Access
Elena Fountzilas, Sofia Karageorgopoulou, Georgios Karakatsoulis, et al.
ESMO Real World Data and Digital Oncology (2025) Vol. 7, pp. 100095-100095
Closed Access
Antibody-Drug Conjugates in Breast Cancer: The Road Towards Biologically-Informed Selection and Sequencing
Tess A. O’Meara, Paolo Tarantino, Stefania Morganti, et al.
Current Oncology Reports (2025)
Closed Access
Tess A. O’Meara, Paolo Tarantino, Stefania Morganti, et al.
Current Oncology Reports (2025)
Closed Access
Disitamab vedotin in preclinical models of HER2-positive breast and gastric cancers resistant to trastuzumab emtansine and trastuzumab deruxtecan
Negar Pourjamal, Vadim Le Joncour, György Vereb, et al.
Translational Oncology (2025) Vol. 53, pp. 102284-102284
Closed Access
Negar Pourjamal, Vadim Le Joncour, György Vereb, et al.
Translational Oncology (2025) Vol. 53, pp. 102284-102284
Closed Access
Systematic Review and Network Meta-Analysis on Treating Hormone Receptor-Positive Metastatic Breast Cancer After CDK4/6 Inhibitors
Neha Pathak, Abhenil Mittal, Sudhir Kumar, et al.
Current Oncology (2025) Vol. 32, Iss. 1, pp. 53-53
Open Access
Neha Pathak, Abhenil Mittal, Sudhir Kumar, et al.
Current Oncology (2025) Vol. 32, Iss. 1, pp. 53-53
Open Access
Antibody-drug conjugates in metastatic breast cancer: sequencing, combinations and resistances
Lorenzo Guidi, Laura Boldrini, Dario Trapani, et al.
Current Opinion in Oncology (2024)
Closed Access | Times Cited: 1
Lorenzo Guidi, Laura Boldrini, Dario Trapani, et al.
Current Opinion in Oncology (2024)
Closed Access | Times Cited: 1
Real-world application of disitamab vedotin (RC48-ADC) in patients with breast cancer with different HER2 expression levels: efficacy and safety analysis
Ke Wang, Ting Xu, Kaichun Wu, et al.
The Oncologist (2024)
Open Access
Ke Wang, Ting Xu, Kaichun Wu, et al.
The Oncologist (2024)
Open Access
Predictive Factors of Antibody–Drug Conjugate Treatment in Metastatic Breast Cancer: A Narrative Review
Gennaro Gadaleta‐Caldarola, Laura Lanotte, Anna Santoro, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 4082-4082
Open Access
Gennaro Gadaleta‐Caldarola, Laura Lanotte, Anna Santoro, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 4082-4082
Open Access
Next Generation of Antibody-Drug Conjugates for Breast Cancer
Shobhit Srivastava, Azeezat O. Osikoya, Dayanidhi Raman
Interdisciplinary cancer research (2024)
Closed Access
Shobhit Srivastava, Azeezat O. Osikoya, Dayanidhi Raman
Interdisciplinary cancer research (2024)
Closed Access
Targeting Refractory Triple-Negative Breast Cancer with Sacituzumab Govitecan: A New Era in Precision Medicine
Saif Khan, Suresh Babu Jandrajupalli, Nashwa Zaki Ali Bushara, et al.
Cells (2024) Vol. 13, Iss. 24, pp. 2126-2126
Open Access
Saif Khan, Suresh Babu Jandrajupalli, Nashwa Zaki Ali Bushara, et al.
Cells (2024) Vol. 13, Iss. 24, pp. 2126-2126
Open Access
